arterial hypertension [dsyn]
Stroke prevention [topp]
Update [tmco]
Blood Pressure, High [dsyn]
Most [qnco]
Risk factor [qnco]
Stroke [dsyn]
Vascular Diseases [dsyn]
Evidence [ftcn]
randomized controlled trials [inpr, resa]
Support [medd]
Anti-Hypertensive Drugs [phsu]
Lower [spco]
Blood Pressure [orgf]
Stroke prevention [topp]
Evidence [ftcn]
Specific [qlco]
Class [inpr]
Anti-Hypertensive Drugs [phsu]
Different [qlco]
effects [qlco]
Pharmacologic Actions [npop]
subgroups [virs]
This [euka]
Review [inpr]
Evaluate [ftcn]
development [phsf]
Therapies [topp]
Late [tmco]
studies [lbpr]
arterial hypertension [dsyn]
Stroke prevention [topp]
Hope [menp]
Trial [resa]
Ramipril [orch, phsu]
placebo [topp]
Trial [resa]
Oil [lipd]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Diuretic [phsu]
Life [idcn]
Trial [resa]
Atenolol [orch, phsu]
progress [ftcn]
Trial [resa]
Perindopril [orch, phsu]
Indapamide [orch, phsu]
placebo [topp]
Result [ftcn]
Relevant [qlco]
Clinical [qlco]
TRAIL [gngm]
Aspect [qnco]
Unresolved [qlco]
Future [tmco]
Clinical Trials [resa]
Hypertension [dsyn]
Stroke prevention [topp]
Answer [inpr]
Following [tmco]
Question [inpr]
lower blood pressure [fndg]
Stroke risk [inpr]
Specific [qlco]
Drug effect [ftcn]
Class [inpr]
Effect [qlco]
Angiotensin II Receptor Blockers [phsu]
Better [qlco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin II Receptor Blockers [phsu]
considered [idcn]
High Risk [qlco]
Stroke [dsyn]
Patients [podg]
Patients [podg]
History [ocdi]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
Blood Pressure [orgf]
Role [socb]
Life Style [socb]
Blood Pressure [orgf]
Control [grup]
